CANF
Can-Fite BioPharma
CANF
CANF
13 hedge funds and large institutions have $472K invested in Can-Fite BioPharma in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$81.5K | |
| 2 | +$14K | |
| 3 | +$9K | |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$2K |
Top Sellers
| 1 | -$169K | |
| 2 | -$36K | |
| 3 | -$23K | |
| 4 |
HF
HRT Financial
New York
|
-$15K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1K |